Evidence on the cost of breast cancer drugs is required for rational decision making

BACKGROUND: For rational decision making, assessing the cost-effectiveness and budget impact of new drugs and comparing the costs of drugs already on the market is required. In addition to value frameworks, such as the American Society of Clinical Oncology Value Framework and the European Society of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ecancermedicalscience
Main Authors: Berghuis, Anne Margreet Sofie, Koffijberg, Hendrik, Terstappen, Leonardus Wendelinus Mathias Marie, Sleijfer, Stefan, IJzerman, Maarten Joost
Formato: Artigo
Idioma:Inglês
Publicado em: Cancer Intelligence 2018
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5931813/
https://ncbi.nlm.nih.gov/pubmed/29743945
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2018.825
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados